Market Place
Sourcing Support
Annora`s Generic Mexiletine Hydrochloride Receives Approval in the U.S.
09 Nov 2022 //
FDA
Zenara`s Generic Ketorolac Tromethamine Receives Approval in the U.S.
26 Aug 2022 //
FDA
UK recall of Clinigen’s Mexiletine hydrochloride hard capsules
05 Aug 2022 //
EUROPEAN PHARMACEUTICAL REVIEW
Medis to commercialise Lupin’s orphan drug NaMuscla to treat myotonia in adults
10 Feb 2022 //
PHARMABIZ
Senores launches Mexiletine HCl Capsules with top generic pharma companies
27 Jan 2022 //
PRNEWSWIRE
Havix`s Generic Mexiletine Hydrochloride Receives Approval in the US
01 Oct 2021 //
FDA
Scottish Medicines Consortium approves Lupin`s NaMuscla® (mexiletine)
08 Dec 2020 //
GLOBENEWSWIRE
Crossmedika SA`s Generic Mexiletine Hydrochloride Receives Approval in US
30 Jul 2020 //
FDA
Lannett Launches Mexiletine HCl Capsules
23 Jul 2020 //
PRNEWSWIRE
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
30 Jun 2020 //
PRNEWSWIRE
Lupin’s mexiletine receives US FDA orphan drug to treat myotonic disorders
07 Jun 2020 //
PHARMABIZ
Lupin`s Namuscla (mexiletine hydrochloride) Receives Approval in Europe
04 Feb 2019 //
FDA
Lupin gets European Commission nod for myotonia treatment drug
08 Jan 2019 //
ECONOMIC TIMES
EMA Recommends the First treatment for rare inherited muscle disorders
20 Oct 2018 //
EMA
Lupin Neurosciences Announces Positive CHMP Opinion for NaMuscla
19 Oct 2018 //
BUSINESS INSIDER
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?
14 Apr 2015 //
FIERCE PHARMA ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.